Annual report pursuant to Section 13 and 15(d)

INCOME TAXES (Tables)

v3.22.1
INCOME TAXES (Tables)
12 Months Ended
Dec. 31, 2021
Income Tax Disclosure [Abstract]  
Schedule of components of income tax expense
               
    2021     2020  
             
Expected federal income tax benefit at statutory rate   $ 8,426,269     $ 288,600  
State income taxes (net of federal benefit)     –       –  
Nondeductible expenses     (224,189 )     (46,600 )
Research and development credit     537,705       –  
Return to provision true up     (94,707 )     –  
Change in valuation allowance     (8,834,492 )     (242,000 )
Income tax benefit     –       –  
Schedule of deferred tax assets and liabilities
               
    2021     2020  
Deferred tax assets                
Net operating losses   $ 5,078,075     $ 242,000  
Depreciation and amortization     46,030       –  
Research & development credit     592,276       –  
Lease liability     466,980       –  
Stock-based compensation     2,872,973       –  
Accrued expenses     478,171       –  
Other     336       –  
Total     9,534,840       242,000  
Valuation allowance     (9,076,492 )     (242,000 )
Net deferred tax asset     458,348       –  
Deferred tax liabilities                
Right of use assets     (458,348 )     –  
Total net deferred taxes Deferred tax liabilities   $ –     $ –